People channel feed

Af­ter falling be­hind the lead­ers, dissed by some ex­perts, biotech show­man Patrick Soon-Sh­iong fi­nal­ly gets his Covid-19 vac­cine ready for a tri­al. But can it live up to the hype?

5 years ago
Coronavirus
In Focus

Patrick Soon-Sh­iong steps down as CEO of Nan­tK­west, a linch­pin of his 'Cancer Moon­shot'

5 years ago

In­di­v­ior's Shaun Thax­ter heads to prison, join­ing In­sys' John Kapoor among jailed opi­oid ex­ecs

5 years ago
Pharma

Mas­ter deal­mak­er David Hung re­tools a SPAC sedan in­to a fi­nanc­ing mus­cle ve­hi­cle that leaves his can­cer start­up with $850M and a place on Wall Street

5 years ago
Deals

Roche finds a home for a new, $500M man­u­fac­tur­ing lo­gis­tics hub, promis­ing 500 jobs

5 years ago
Outsourcing
Pharma

The prospect of an Oc­to­ber OK large­ly closed, Pfiz­er's Al­bert Bourla promis­es not to sub­mit for EUA un­til No­vem­ber

5 years ago
Pharma
Coronavirus

No­var­tis vet Dan­ny Bar-Zo­har leaps back in­to R&D, tak­ing over the de­vel­op­ment team at Mer­ck KGaA as Lu­ciano Ros­set­ti steps out

5 years ago

Keep­ing an 'im­mi­grant mind­set,' Flag­ship taps a self-pro­fessed no­mad as CEO for their next-gen vi­ral vec­tor up­start

5 years ago

A long-haul biotech with some im­pres­sive back­ers and big goals re­cruits a ma­jor league R&D ex­ec to the helm. What’s next?

5 years ago
Startups

Months af­ter re­tir­ing from Genen­tech, Michael Var­ney brings his drug hunt­ing eye to Fra­zier

5 years ago
Financing

GSK's Em­ma Walm­s­ley grant­ed dame­hood by Queen Eliz­a­beth II

5 years ago

Em­bat­tled Har­vard sci­en­tist Charles Lieber goes on a counter-of­fen­sive, hir­ing high-pro­file lawyer and su­ing Har­vard for aban­don­ing him amid fed­er­al probe

5 years ago

Sa­mi An­war raked in mil­lions of dol­lars gath­er­ing drug tri­al da­ta at his sites. But it was all a lie — and now he's been sen­tenced to 28 years

5 years ago
Pharma

BAR­DA chief turned whistle­blow­er Rick Bright re­signs from gov­ern­ment with one last broad­side against the Trump ad­min­is­tra­tion

5 years ago
Coronavirus

Em­manuelle Char­p­en­tier and Jen­nifer Doud­na win the No­bel Prize for ground­break­ing CRISPR dis­cov­ery

5 years ago
R&D

The lat­est Jen­nifer Doud­na start­up launch­es with a Bio­gen part­ner­ship and eyes on big tar­gets few CRISPR com­pa­nies have chased

5 years ago
Startups

Laid off from Im­muno­Gen, an ex-Gen­zyme and Shire ex­ec heads to an ARCH up­start

5 years ago
Financing

Har­vard 'MacArthur ge­nius’ Kevin Eggan steps in to run ear­ly-stage re­search at rare dis­ease spe­cial­ist Bio­Marin

5 years ago
R&D

Three sci­en­tists win No­bel Prize in Med­i­cine for work in dis­cov­er­ing he­pati­tis C virus

5 years ago
Discovery

Two top ex­ecs in Sanofi's R&D group are hit­ting the ex­it in a shake­up as Frank Nes­tle moves up to CSO

5 years ago

Mer­ck R&D chief Roger Perl­mut­ter is hand­ing off the big job to the ex­ec in charge of dis­cov­ery

5 years ago
R&D

C4's An­drew Hirsch blows up IPO to $182M, while on­colyt­ic virus up­start nabs $87M of­fer­ing

5 years ago
Financing
R&D

With a po­ten­tial FDA ap­proval loom­ing, G1 Ther­a­peu­tics taps ex-GSK US pres­i­dent Jack Bai­ley as new CEO

5 years ago
R&D

A sec­ond Carl Ic­ahn pro­tégé jumps in on SPAC spree, as Alex Den­ner guns for $175M

5 years ago
Financing
First page Previous page 64656667686970 Next page Last page
A service from the Financial Times